Patents by Inventor Murray Ducharme

Murray Ducharme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9789108
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Grant
    Filed: December 10, 2014
    Date of Patent: October 17, 2017
    Assignee: Hikma Pharmaceuticals LLC
    Inventor: Murray Ducharme
  • Patent number: 9675613
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: June 13, 2017
    Assignee: Hikma Pharmaceuticals LLC
    Inventor: Murray Ducharme
  • Patent number: 9555029
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: January 31, 2017
    Assignee: HIKMA PHARMACEUTICALS LLC
    Inventor: Murray Ducharme
  • Patent number: 9399036
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Grant
    Filed: December 10, 2014
    Date of Patent: July 26, 2016
    Assignee: Hikma Pharmaceuticals LLC
    Inventor: Murray Ducharme
  • Publication number: 20150094318
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Application
    Filed: December 10, 2014
    Publication date: April 2, 2015
    Applicant: HIKMA PHARMACEUTICALS LLC
    Inventor: Murray Ducharme
  • Publication number: 20150094375
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Application
    Filed: December 11, 2014
    Publication date: April 2, 2015
    Applicant: Hikma Pharmaceuticals LLC
    Inventor: Murray Ducharme
  • Publication number: 20150094317
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Application
    Filed: December 10, 2014
    Publication date: April 2, 2015
    Applicant: Hikma Pharmaceuticals LLC
    Inventor: Murray DUCHARME
  • Publication number: 20150057359
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Application
    Filed: October 10, 2014
    Publication date: February 26, 2015
    Applicant: HIKMA PHARMACEUTICALS LLC
    Inventor: Murray Ducharme
  • Patent number: 8927607
    Abstract: The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: January 6, 2015
    Assignee: Hikma Pharmaceuticals LLC
    Inventor: Murray Ducharme